Treatment response biomarkers: working towards personalised radiotherapy for lung cancer.

Horne, Ashley; Harada, Ken; Brown, Katherine D; Chua, Kevin Lee Min; McDonald, Fiona; Price, Gareth; Putora, Paul Martin; Rothwell, Dominic G; Faivre-Finn, Corinne (2024). Treatment response biomarkers: working towards personalised radiotherapy for lung cancer. (In Press). Journal of thoracic oncology Elsevier 10.1016/j.jtho.2024.04.006

[img]
Preview
Text
1-s2.0-S1556086424001643-main.pdf - Accepted Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (713kB) | Preview

Due to major advances in the field of radiation oncology, patients with lung cancer (LC) can now receive technically individualised radiotherapy treatments. However, in the era of precision oncology, radiotherapy-based treatment selection needs to be improved as many patients do not benefit or are not offered optimum therapies. Cost-effective robust biomarkers can address this knowledge gap and lead to individuals being offered more bespoke treatments leading to improved outcome. This narrative review discusses some of the current achievements and challenges in the realisation of personalised radiotherapy delivery in patients with LC.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology

UniBE Contributor:

Putora, Paul Martin

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1556-1380

Publisher:

Elsevier

Language:

English

Submitter:

Pubmed Import

Date Deposited:

16 Apr 2024 08:48

Last Modified:

17 Apr 2024 15:39

Publisher DOI:

10.1016/j.jtho.2024.04.006

PubMed ID:

38615939

BORIS DOI:

10.48350/195965

URI:

https://boris.unibe.ch/id/eprint/195965

Actions (login required)

Edit item Edit item
Provide Feedback